Brief: Nuvectis Pharma Inc Reports First Quarter 2022 Financial Results
10/05/2022 13:55
May 10 (Reuters) - Nuvectis Pharma Inc NVCT.O :
* NUVECTIS PHARMA, INC. REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* NUVECTIS PHARMA INC QTRLY LOSS PER SHARE $0.32
Source text for Eikon: ID:nGNX5FcFWs
Further company coverage: NVCT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nuvectis Pharma
See all newsNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Nuvectis Pharma Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Ciprocopan (NXP100) Receives Marketing Approval In China For The Treatment Of Patients With PNH Previously Untreated With Complement Inhibitors
U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin